Status:
COMPLETED
Vaccine for Recurrent Urinary Tract Infections in Women
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Recurrent Urinary Tract Infections in Women
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-mont...
Detailed Description
Recurrent urinary tract infections (UTIs) affect approximately 10% of women in the United States. Since antibiotic prophylaxis is not always effective, alternate treatments need to be developed. One s...
Eligibility Criteria
Inclusion
- Three or more urinary tract infections in the previous year
Exclusion
- Neurogenic bladder
- Interstitial cystitis
- Urinary diversion
- Kidney stones
- Indwelling catheter
Key Trial Info
Start Date :
November 1 1996
Trial Type :
INTERVENTIONAL
End Date :
December 1 2003
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00261248
Start Date
November 1 1996
End Date
December 1 2003
Last Update
October 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792